Product Details for NDA 020632
MERIDIA (SIBUTRAMINE HYDROCHLORIDE)
5MG
Marketing Status: Discontinued
10MG
Marketing Status: Discontinued
15MG
Marketing Status: Discontinued
5MG
Marketing Status: Discontinued
Active Ingredient: SIBUTRAMINE HYDROCHLORIDE
Proprietary Name: MERIDIA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020632
Product Number: 001
Approval Date: Nov 22, 1997
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
MERIDIA (SIBUTRAMINE HYDROCHLORIDE)
Proprietary Name: MERIDIA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020632
Product Number: 001
Approval Date: Nov 22, 1997
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
10MG
Marketing Status: Discontinued
Active Ingredient: SIBUTRAMINE HYDROCHLORIDE
Proprietary Name: MERIDIA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020632
Product Number: 002
Approval Date: Nov 22, 1997
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
MERIDIA (SIBUTRAMINE HYDROCHLORIDE)
Proprietary Name: MERIDIA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 10MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020632
Product Number: 002
Approval Date: Nov 22, 1997
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
15MG
Marketing Status: Discontinued
Active Ingredient: SIBUTRAMINE HYDROCHLORIDE
Proprietary Name: MERIDIA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020632
Product Number: 003
Approval Date: Nov 22, 1997
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: MERIDIA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 15MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N020632
Product Number: 003
Approval Date: Nov 22, 1997
Applicant Holder Full Name: ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Marketing Status: Discontinued
Patent and Exclusivity Information